Evidence map›Paper›PMID 20863807›Full record

ArticleAnalytical biochemistry2011

A modified fluorescent intercalator displacement assay for RNA ligand discovery.

Papa Nii Asare-Okai, Christine S Chow

Abstract read
In one paragraph

Article in Analytical biochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Targeting RNA structures with small molecules.Nature reviews. Drug discovery · 2022
    Review
  6. Article
  7. Article
  8. Chembiochem : a European journal of chemical biology · 2021
    Article
  9. Small molecule targeting r(UGGAA)Nature communications · 2021
    Article
  10. Article
  11. Target-Directed Approaches for Screening Small Molecules against RNA Targets.SLAS discovery : advancing life sciences R & D · 2020
    Review
  12. RNA-Targeted Therapies and High-Throughput Screening Methods.International journal of molecular sciences · 2020
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Papa Nii Asare-OkaiDepartment of Chemistry, Wayne State University, Detroit, MI 48202, USA.
Christine S Chow

Funding

RIBOSOMAL FUNCTION &ANTIBIOTIC DESIGNR01AI055496 · NIAID · WAYNE STATE UNIVERSITY · PI MOBASHERY, SHAHRIAR · 2003 to 2007
$1.3M
The Role of Ribosomal RNA ModificationsR01GM087596 · NIGMS · WAYNE STATE UNIVERSITY · PI CHOW, CHRISTINE S · 2009 to 2012
$1.1M
NIAID NIH HHS AI055496NIAID NIH HHS R01 AI055496NIGMS NIH HHS GM087596NIGMS NIH HHS R01 GM087596
6 · The paper itself

Abstract

Fluorescent intercalator displacement (FID) is a convenient and practical tool for identifying new nucleic acid-binding ligands. The success of FID is based on the fact that it can be fashioned into a versatile screening assay for assessing the relative binding affinities of compounds to nucleic acids. FID is a tagless approach; the target RNAs and the ligands or small molecules under investigation do not need to be modified in order to be examined. In this study, a modified FID assay for screening RNA-binding ligands was established using 3-methyl-2-((1-(3-(trimethylammonio)propyl)-4-quinolinylidene)methyl)benzothiazolium (TO-PRO) as the fluorescent indicator. Electrospray ionization mass spectrometry (ESI-MS) results provide direct evidence that correlates the reduction in fluorescence intensity observed in the FID assay with displacement of the dye molecule from RNA. The assay was successfully applied to screen a variety of RNA-binding ligands with a set of small hairpin RNAs. Ligands that bind with moderate affinity to the chosen RNA constructs (A-site, TAR [transactivation response element], h31 [helix 31], and H69 [helix 69] were identified.

Indexed as

LigandsBenzothiazolesChloramphenicolFluorescent DyesHIV Long Terminal RepeatIntercalating AgentsParomomycinRNARNA, TransferSpectrometry, Mass, Electrospray Ionizationtat Gene Products, Human Immunodeficiency VirusBenzothiazolesChloramphenicolFluorescent DyesIntercalating AgentsLigandsParomomycinRNARNA, Transfertat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID20863807
PMCPMC2980581

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.